Please login to the form below

Not currently logged in
Email:
Password:

Firmagon

This page shows the latest Firmagon news and features for those working in and with pharma, biotech and healthcare.

NICE finally set to back wider use of Ferring's Firmagon

NICE finally set to back wider use of Ferring's Firmagon

Ferring's Firmagon (degarelix) has been recommended for use by the NHS in England by the country's cost-effectiveness watchdog NICE. ... This has been a long process but throughout … we have maintained our firm belief that Firmagon can have a

Latest news

  • NICE gives partial backing to Ferring's prostate cancer drug NICE gives partial backing to Ferring's prostate cancer drug

    said. "Patients with pre-existing CVD are most at risk and the evidence shows that Firmagon has a higher chance of reducing that.". ... Ferring estimates that Firmagon costs around £12, 300 ($20, 650) per course - including administration - which NICE

  • Close but no cigar

    Acne vulgaris. US, Europe. Degarelix. FIRMAGON (Ferring). Prostate cancer. US. Lanthanum carbonate.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics